Studying Cancer Evolution and Therapeutic Responses in Different Organs: The Pros and Cons of a Broad Focus

Cancer Res. 2019 Sep 15;79(18):4582-4584. doi: 10.1158/0008-5472.CAN-19-1303. Epub 2019 Aug 22.

Abstract

Cellular adaptation brought upon by insults such as old age and therapeutic exposure is a complex phenomenon in which cells undergo adaptive phenotypic changes. Our lab has focused on understanding the mechanisms underlying adaptation during the evolution of cancer, from the early stages of development to the ability of cancer cells to escape therapeutic challenges. Our studies span hematopoietic and lung systems. Herein, we discuss the advantages and disadvantages involved in studying two vastly different organ systems. Through the use of these organ/cancer model systems, we hope to develop interventions to limit oncogenic adaptation leading to cancer development and to prevent adaptation of cancers following treatment leading to cancer relapse.

MeSH terms

  • Adaptation, Physiological*
  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Clonal Evolution*
  • Disease Progression
  • Humans
  • Molecular Targeted Therapy
  • Neoplasms / drug therapy
  • Neoplasms / pathology*
  • Tumor Microenvironment / drug effects*

Substances

  • Antineoplastic Agents